Am J Health Syst Pharm. 2010;67(14):1157-1164. Vernakalant hydrochloride injection, an antiarrhythmic agent under review by the Food and Drug Administration (FDA) for the rapid conversion of AF to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback